BASi In Vivo News - August 2011
 Montreal, Canada
August 21-25
BASi Evansville General Manager John Devine Jr., DABT, will be co-chairing a symposium “Biological and Biotechnology-Based Therapeutics” at this conference August 23rd in Montreal. This session will examine the challenges and potential solutions to the development and safety testing of biological and biotechnology-based therapeutics.
Click here for more information on how the BASi Culex® Automated In Vivo Sampling System can reduce stress and the number of animals used for studies.
Applied Pharmaceutical Analysis 2011
Smaller & Smarter: Rising up to meet Quantitative & Qualitative Bioanalytical Challenges
Cambridge, MA
September 11-14
BASi representatives attending:
Lori Payne, PhD., Northwest Labs General Manager
Michael Zhou, PhD., Senior Director of Research and Development
BASi Poster Presentations
“The Culex® Automated In Vivo Sampling System: A Novel Technique for Dried Blood Spot (DBS) Collection in Preclinical Studies”
Despite the well documented benefits of DBS sampling, the manual spotting of blood samples onto DBS cards is a labor intensive process. This poster describes a novel automated technique, using the Culex® Automated In Vivo Blood Sampling System, for directly collecting whole blood samples in the DBS format.
“A Pharmacokinetic Evaluation of Acetaminophen in Dog Plasma and Dried Blood Spots Using Automated Blood Collection”
It is possible regulatory agencies will require submission of data from dual sampling techniques to ensure the validity of data from DBS. BASi seeks to reduce inter-method variability by simultaneously collecting plasma and DBS from the same animal using the Culex® Automated Blood Collection System and then to compare the toxicokinetic parameters.
BASi reports third quarter earnings
Bioanalytical Systems, Inc. (Nasdaq: BASI) announced today that revenue for the third quarter of fiscal 2011 ended June 30, 2011 increased 5.1% to $8,478,000 from $8,064,000 for the third quarter of fiscal 2010. Net income for this year's third quarter increased 45.1% to $418,000 compared to $288,000 a year ago.
See the full news release for more information.
Upcoming Events
Safety Pharmacology Society
Innsbruck, Austria
September 19-22
Booth #123
American Association for Laboratory Animal Science
San Diego, CA
October 2-6
Booth #1335
ISSX International Society for the Study of Xenobiotics
October 16-20
Atlanta, GA
Booth #1309
AAPS – American Association of Pharmaceutical Scientists
Washington DC
October 23-27
Booth # 829
BASi on Facebook, Twitter and LinkedIN
Get up-to-the second BASi news and information from the following links:
For more information about items in this newsletter, or any other BASi product, call 1-800-845-4246, or contact us.
|
